Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Qtern (dapagliflozin and saxagliptin) for the Treatment of Type 2 Diabetes

Drug (Brand / Generic)

Qtern / dapagliflozin and saxagliptin

Developer

AstraZeneca

Therapy Class

Anti-diabetes drug

Product Description

Sodium/glucose cotransporter (SGLT) 2, and dipeptidyl peptidase 4 (DPP-4) inhibitors

Current Indication

Type 2 Diabetes

Market Sector

Metabolic disorders

Development Status

Approved in the US, Iceland, Liechtenstein, Norway and Europe
Expand

Go Top